Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Overman

Showing results (141-150 of 265) with videos related to

Pageof 27
Sort By:
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|January 15, 2020
Modified FOLFIRINOX in pancreatic cancer patients Age 75 or olderJonathan D Mizrahi, Jane E Rogers, Kenneth R Hess, et al.
Investigational New Drugs|June 12, 2015
Phase II study of saracatinib (AZD0530) in patients with previously treated metastatic colorectal cancerS M Reddy, S Kopetz, J Morris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2021
ZEBRA: A Multicenter Phase II Study of Pembrolizumab in Patients with Advanced Small-Bowel AdenocarcinomaKatrina S Pedersen, Nathan R Foster, Michael J Overman, et al.
Genes, Chromosomes & Cancer|June 22, 2000
Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1S A Rasmussen, J Overman, S A Thomson, et al.
Oncotarget|April 21, 2017
FBXW7 missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinomaKrittiya Korphaisarn, Van Karlyle Morris, Michael J Overman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 10, 2022
Radiographic and Serologic Response to First-Line Chemotherapy in Unresected Localized Pancreatic CancerCaitlin A Hester, Giampaolo Perri, Laura R Prakash, et al.
JCO Precision Oncology|November 22, 2024
Genomic Alterations in DNA Mismatch Repair Genes Across Different Cancer TypesVijaykumar R Holla, Michael P Kahle, Sun-Hee Kim, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 3, 2017
Long-Term Remissions of Patients With Follicular Lymphoma Grade 3 Treated With R-CHOPPaolo Strati, Nathan Fowler, Sergio Pina-Oviedo, et al.
Annals of Surgical Oncology|July 12, 2017
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Moderately and Poorly Differentiated Appendiceal Adenocarcinoma: Survival Outcomes and Patient SelectionTravis E Grotz, Michael J Overman, Cathy Eng, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 8, 2025
Physical Activity and Dexamethasone for Cancer-Related Fatigue: A Preliminary Placebo-Controlled, Randomized, Double-Blind TrialSriram Yennurajalingam, Vicente Valero, Brandon G Smalgo, et al.
Pageof 27

Showing results (141-150 of 265) with videos related to

Sort By:
Pageof 27
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|January 15, 2020
Modified FOLFIRINOX in pancreatic cancer patients Age 75 or olderJonathan D Mizrahi, Jane E Rogers, Kenneth R Hess, et al.
Investigational New Drugs|June 12, 2015
Phase II study of saracatinib (AZD0530) in patients with previously treated metastatic colorectal cancerS M Reddy, S Kopetz, J Morris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2021
ZEBRA: A Multicenter Phase II Study of Pembrolizumab in Patients with Advanced Small-Bowel AdenocarcinomaKatrina S Pedersen, Nathan R Foster, Michael J Overman, et al.
Genes, Chromosomes & Cancer|June 22, 2000
Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1S A Rasmussen, J Overman, S A Thomson, et al.
Oncotarget|April 21, 2017
FBXW7 missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinomaKrittiya Korphaisarn, Van Karlyle Morris, Michael J Overman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 10, 2022
Radiographic and Serologic Response to First-Line Chemotherapy in Unresected Localized Pancreatic CancerCaitlin A Hester, Giampaolo Perri, Laura R Prakash, et al.
JCO Precision Oncology|November 22, 2024
Genomic Alterations in DNA Mismatch Repair Genes Across Different Cancer TypesVijaykumar R Holla, Michael P Kahle, Sun-Hee Kim, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 3, 2017
Long-Term Remissions of Patients With Follicular Lymphoma Grade 3 Treated With R-CHOPPaolo Strati, Nathan Fowler, Sergio Pina-Oviedo, et al.
Annals of Surgical Oncology|July 12, 2017
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Moderately and Poorly Differentiated Appendiceal Adenocarcinoma: Survival Outcomes and Patient SelectionTravis E Grotz, Michael J Overman, Cathy Eng, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 8, 2025
Physical Activity and Dexamethasone for Cancer-Related Fatigue: A Preliminary Placebo-Controlled, Randomized, Double-Blind TrialSriram Yennurajalingam, Vicente Valero, Brandon G Smalgo, et al.
Pageof 27